CRAC channels as targets for immunotherapy
Authors:
- 22 April 2026
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 100, 102780
Abstract
No abstract availableKeywords
Funding Information
- Melanoma Research Alliance (1044906)
- National Institutes of Health (AI137004)
- National Institutes of Health (AI180128)
This publication has 90 references indexed in Scilit:
- CRAC channels as targets for drug discovery and developmentCell Calcium, 2018
- Deletion of Orai2 augments endogenous CRAC currents and degranulation in mast cells leading to enhanced anaphylaxisCell Calcium, 2018
- Differential Ca2+ mobilization and mast cell degranulation by FcεRI- and GPCR-mediated signalingCell Calcium, 2017
- The STIM-Orai Pathway: The Interactions Between STIM and Orai2017
- Orai1 controls C5a‐induced neutrophil recruitment in inflammationEuropean Journal of Immunology, 2015
- Calcium signaling in pancreatic ductal epithelial cells: An old friend and a nasty enemyCell Calcium, 2014
- STIM1 and STIM2‐mediated Ca2+ influx regulates antitumour immunity by CD8+ T cellsEMBO Molecular Medicine, 2013
- The action of selective CRAC channel blockers is affected by the Orai pore geometryCell Calcium, 2013
- The Neglected CRAC Proteins2013
- T‐cell‐specific deletion of STIM1 and STIM2 protects mice from EAE by impairing the effector functions of Th1 and Th17 cellsEuropean Journal of Immunology, 2010